✦ LIBER ✦

Comparison of extended-release venlafaxine, selective serotonin reuptake inhibitors, and tricyclic antidepressants in the treatment of depression: A meta-analysis of randomized controlled trials

✍ Scribed by Thomas R. Einarson; Steven R. Arikian; Julian Casciano; John J. Doyle

Book ID: 117320999
Publisher: Elsevier Science
Year: 1999
Tongue: English
Weight: 813 KB
Volume: 21
Category: Article
ISSN: 0149-2918
DOI: 10.1016/s0149-2918(00)88287-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P.2.041 Meta-analysis of all known rando

P.2.041 Meta-analysis of all known randomized controlled trials comparing venlafaxine and selective serotonin reuptake inhibitors in depression

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 119 KB

A comparison of side effects of selectiv

A comparison of side effects of selective serotonin reuptake inhibitors and tricyclic antidepressants in older depressed patients: a meta-analysis

✍ Kenneth Wilson; Pat Mottram 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 114 KB

## Abstract ## Objective To examine the relative tolerability and side effect profile of tricyclic antidepressants and selective serotonin reuptake inhibitors in older depressed people. ## Methods A systematic literature search generated 37 randomised controlled trials of TCAs and SSRIs of which

The treatment of depression in UK genera

The treatment of depression in UK general practice: selective serotonin reuptake inhibitors and tricyclic antidepressants compared

✍ R.A Lawrenson; F Tyrer; R.B Newson; R.D.T Farmer 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 510 KB

Randomised controlled trials of selectiv

Randomised controlled trials of selective serotonin reuptake inhibitors in treating depression in children and adolescents: A systematic review and meta-analysis

✍ Tatiana Usala; Antonio Clavenna; Alessandro Zuddas; Maurizio Bonati 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 832 KB

A meta-analysis of clinical trials compa

A meta-analysis of clinical trials comparing milnacipran, a serotonin–norepinephrine reuptake inhibitor, with a selective serotonin reuptake inhibitor for the treatment of major depressive disorder

✍ George I. Papakostas; Maurizio Fava 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 156 KB

A meta-analysis of clinical trials compa

A meta-analysis of clinical trials comparing reboxetine, a norepinephrine reuptake inhibitor, with selective serotonin reuptake inhibitors for the treatment of major depressive disorder

✍ George I. Papakostas; J. Craig Nelson; Siegfried Kasper; Hans-Jürgen Möller 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 209 KB